In March 2025, the company declared new plans for just a direct-to-client providing of its Wegovy weight loss drug. The company recognized a new pharmacy, known as NovoCare, which would cost customers $499 each month for usage of the drug, below fifty percent the expense of the drug by means of other pharmaceutical distribution networks.[53]that wi